IDR-Induced CAR Condensation Improves the Cytotoxicity of CAR-Ts against Low-Antigen Cancers

Scientists engineered CARs targeting CD19, CD22, and HER2 by including intrinsically disordered regions (IDRs) that promote signaling condensation.